88 related articles for article (PubMed ID: 2981461)
1. Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction.
Hock CE; Ribeiro LG; Lefer AM
Am Heart J; 1985 Feb; 109(2):222-8. PubMed ID: 2981461
[TBL] [Abstract][Full Text] [Related]
2. CGS-12970, a thromboxane synthetase inhibitor, limits ischemic damage following coronary artery occlusion.
Hock CE; Lefer AM
Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):285-94. PubMed ID: 3755540
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of KW-3049, a new 1,4-dihydropyridine calcium antagonist, on the reduction of myocardial creatine kinase activity and high-energy phosphate content in rats subjected to coronary artery ligation.
Karasawa A; Kubo K
J Pharmacobiodyn; 1988 Nov; 11(11):722-9. PubMed ID: 3236204
[TBL] [Abstract][Full Text] [Related]
4. Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction.
Hock CE; Phillips GR; Lefer AM
Prostaglandins Leukot Med; 1985 Mar; 17(3):339-46. PubMed ID: 3857643
[TBL] [Abstract][Full Text] [Related]
5. Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemia.
Hock CE; Brezinski ME; Lefer AM
Eur J Pharmacol; 1986 Mar; 122(2):213-9. PubMed ID: 3011442
[TBL] [Abstract][Full Text] [Related]
6. Failure of captopril to attenuate myocardial damage, neutrophil accumulation, and mortality following coronary artery occlusion and reperfusion in rat.
Leor J; Varda-Bloom N; Hasdai D; Ovadia Z; Battler A
Angiology; 1994 Aug; 45(8):717-24. PubMed ID: 8048781
[TBL] [Abstract][Full Text] [Related]
7. Additive beneficial effects of two inhibitors of vasoconstrictor mediators in acute myocardial ischemia.
Bitterman H; Lefer DJ; Lefer AM
Proc Soc Exp Biol Med; 1987 Jul; 185(3):262-6. PubMed ID: 3037554
[TBL] [Abstract][Full Text] [Related]
8. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of enalapril in acute myocardial ischemia.
Lefer AM; Peck RC
Pharmacology; 1984; 29(2):61-9. PubMed ID: 6206518
[TBL] [Abstract][Full Text] [Related]
10. Increased angiotensin-converting enzyme activity in the left ventricle after infarction.
Busatto VC; Cicilini MA; Mill JG
Braz J Med Biol Res; 1997 May; 30(5):679-87. PubMed ID: 9283639
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
[TBL] [Abstract][Full Text] [Related]
12. Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
Smith EF; Griswold DE; Egan JW; Hillegass LM; DiMartino MJ
J Cardiovasc Pharmacol; 1989 May; 13(5):715-22. PubMed ID: 2472519
[TBL] [Abstract][Full Text] [Related]
13. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
Freeman JG; Hock CE; Edmonds JS; Lefer AM
J Pharmacol Exp Ther; 1984 Dec; 231(3):610-5. PubMed ID: 6094795
[TBL] [Abstract][Full Text] [Related]
14. Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion.
Smith EF; Egan JW; Griswold DE
Pharmacology; 1989; 38(5):298-309. PubMed ID: 2527373
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
16. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
[TBL] [Abstract][Full Text] [Related]
17. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist.
Nichols WW; Mehta J; Wargovich TJ; Franzini D; Lawson D
Angiology; 1989 Mar; 40(3):209-21. PubMed ID: 2537051
[TBL] [Abstract][Full Text] [Related]
18. Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors.
Leenen FH; Skarda V; Yuan B; White R
Am J Physiol; 1999 Jan; 276(1):H317-25. PubMed ID: 9887046
[TBL] [Abstract][Full Text] [Related]
19. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
[TBL] [Abstract][Full Text] [Related]
20. Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
Hügel S; Horn M; Remkes H; Dienesch C; Neubauer S
J Cardiovasc Magn Reson; 2001; 3(3):215-25. PubMed ID: 11816618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
